0,914  0,003  Renal disease treatment
0,911  0,004  Lipoprotein disorders treatment
0,905  0,001  Glutamate decarboxylase inhibitor
0,893  0,001  Aconitate hydratase inhibitor
0,893  0,004  Eye irritation, high
0,862  0,003  Urolithiasis treatment
0,850  0,004  GST A substrate
0,847  0,002  Alcohol oxidase inhibitor
0,836  0,005  Antidiabetic
0,836  0,005  Cyclophilin D inhibitor
0,835  0,004  Antihypertensive
0,833  0,004  Hypolipemic
0,827  0,004  Heart failure treatment
0,818  0,002  Alpha-N-acetylglucosaminidase inhibitor
0,811  0,003  Renal failure treatment
0,782  0,001  Glutamate dehydrogenase inhibitor
0,759  0,004  Skin irritative effect
0,732  0,005  Antidiabetic (type 2)
0,733  0,012  TNF expression inhibitor
0,723  0,005  Cardiotonic
0,719  0,007  Aldehyde oxidase inhibitor
0,688  0,004  Antiischemic, cerebral
0,683  0,005  Urologic disorders treatment
0,670  0,001  Fumarate hydratase inhibitor
0,676  0,008  Vasodilator, peripheral
0,669  0,002  GABA C receptor agonist
0,668  0,008  Stroke treatment
0,667  0,010  Sensitization
0,662  0,007  Antiischemic
0,647  0,006  Hypoglycemic
0,636  0,001  Carbamoyl phosphate synthetase inhibitor
0,633  0,001  Phosphofructokinase-1 inhibitor
0,641  0,010  Atherosclerosis treatment
0,631  0,002  Triose-phosphate isomerase inhibitor
0,640  0,014  Antineoplastic (solid tumors)
0,636  0,014  Antihypercholesterolemic
0,621  0,006  Platelet antagonist
0,622  0,008  Apoptosis antagonist
0,598  0,003  GST P1-1 substrate
0,600  0,005  Antihypertriglyceridemic
0,605  0,017  Carcinogenic
0,603  0,018  Cholesterol antagonist
0,585  0,003  Peroxisome proliferator-activated receptor gamma agonist
0,594  0,021  CYP2C9 substrate
0,569  0,005  Peroxidase inhibitor
0,561  0,002  Excitatory amino acid transporter EAAC1 inhibitor
0,568  0,013  NOS3 expression inhibitor
0,545  0,003  Succinate dehydrogenase inhibitor
0,560  0,017  Antipruritic, allergic
0,559  0,021  Antithrombotic
0,539  0,013  FMO1 substrate
0,538  0,016  Ulceration
0,539  0,022  5 Hydroxytryptamine release inhibitor
0,534  0,019  Histamine release inhibitor
0,522  0,008  UGT2B4 substrate
0,547  0,034  CYP3A4 substrate
0,532  0,022  5 Hydroxytryptamine release stimulant
0,526  0,018  Hepatic disorders treatment
0,503  0,006  Restenosis treatment
0,514  0,020  Cardioprotectant
0,493  0,003  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,483  0,002  Catalase inhibitor
0,508  0,031  Immunosuppressant
0,479  0,003  Ferrochelatase inhibitor
0,495  0,021  Mutagenic
0,483  0,013  Antidiabetic symptomatic
0,486  0,022  UGT1A9 substrate
0,488  0,024  Radioprotector
0,482  0,024  Analeptic
0,470  0,013  Acute neurologic disorders treatment
0,481  0,025  Antifungal
0,460  0,004  Carcinogenic, group 1
0,510  0,056  Caspase 9 stimulant
0,449  0,004  Antihyperlipoproteinemic
0,476  0,032  Respiratory analeptic
0,469  0,025  Chemoprotective
0,451  0,013  Interleukin agonist
0,438  0,005  Tyrosine 3 hydroxylase inhibitor
0,441  0,010  Abortion inducer
0,445  0,016  Antihypoxic
0,445  0,016  Interleukin 2 agonist
0,443  0,017  Radiosensitizer
0,461  0,037  Teratogen
0,450  0,028  CTGF expression inhibitor
0,441  0,019  UGT1A6 substrate
0,425  0,004  Porphobilinogen synthase inhibitor
0,416  0,003  Phenylalanine 4-hydroxylase inhibitor
0,416  0,006  Insulin secretagoues
0,421  0,013  FMO3 substrate
0,418  0,012  Sodium/bile acid cotransporter inhibitor
0,412  0,009  Antipruritic, non-allergic
0,406  0,006  Glutathione S-transferase substrate
0,443  0,044  GABA C receptor rho-3 antagonist
0,410  0,011  UGT1A3 substrate
0,436  0,038  Embryotoxic
0,434  0,037  CYP2D6 substrate
0,409  0,013  5 Hydroxytryptamine uptake stimulant
0,430  0,034  CYP1A2 substrate
0,402  0,006  Insulin sensitizer
0,406  0,011  GST M1-1 substrate
0,403  0,011  Thrombolytic
0,406  0,014  UGT1A4 substrate
0,414  0,023  Cardiodepressant
0,400  0,011  UGT2B7 substrate
0,392  0,003  Adenylate kinase inhibitor
0,389  0,005  Cell adhesion inhibitor
0,393  0,009  Protein-tyrosine phosphatase inhibitor
0,437  0,053  Antiobesity
0,404  0,021  Myocardial infarction treatment
0,423  0,043  Immunostimulant
0,388  0,010  VCAM1 expression inhibitor
0,399  0,027  Antipyretic
0,376  0,011  Amylase inhibitor
0,369  0,005  Cell adhesion molecule inhibitor
0,393  0,031  Cardiovascular analeptic
0,376  0,019  Growth hormone agonist
0,359  0,005  Antispirochetal
0,378  0,023  Antiulcerative
0,392  0,038  Vasodilator, coronary
0,356  0,003  Biliverdin reductase inhibitor
0,390  0,037  Cytotoxic
0,358  0,006  Aldose reductase substrate
0,392  0,042  CYP2C19 substrate
0,383  0,036  Cytostatic
0,374  0,027  Vascular (periferal) disease treatment
0,416  0,070  Antibacterial
0,369  0,024  UDP-glucuronosyltransferase substrate
0,369  0,028  Pyruvate kinase inhibitor
0,368  0,027  DNA synthesis inhibitor
0,373  0,032  Superoxide dismutase inhibitor
0,346  0,007  Cholesterol synthesis inhibitor
0,346  0,012  Protein kinase stimulant
0,338  0,005  Histidine decarboxylase inhibitor
0,341  0,008  Aldehyde dehydrogenase inhibitor
0,337  0,006  NADH dehydrogenase inhibitor
0,353  0,023  Anesthetic general
0,358  0,028  Flavin-containing monooxygenase substrate
0,344  0,015  Phospholipase C inhibitor
0,338  0,014  Gastrin inhibitor
0,364  0,040  NOS2 expression inhibitor
0,339  0,018  Antiseptic
0,348  0,033  Angiogenesis stimulant
0,314  0,001  Glucose-6-phosphate isomerase inhibitor
0,314  0,004  UGT2B10 substrate
0,315  0,005  Antineoplastic, alkylator
0,330  0,022  Hepatoprotectant
0,334  0,026  Septic shock treatment
0,310  0,003  Neutral endopeptidase inhibitor
0,329  0,022  Antimutagenic
0,311  0,005  Mannose-6-phosphate isomerase inhibitor
0,315  0,009  UDP-glucose 4-epimerase inhibitor
0,341  0,037  Insulysin inhibitor
0,329  0,026  UGT1A1 substrate
0,338  0,037  Vasodilator
0,360  0,062  Bone diseases treatment
0,302  0,006  Alcohol dehydrogenase substrate
0,300  0,009  Expectorant
0,325  0,037  Psychostimulant
0,296  0,011  UGT2B9 substrate
0,292  0,011  Protein-tyrosine phosphatase 1B inhibitor
0,289  0,011  Aldehyde oxidase substrate
0,282  0,005  Prostaglandin EP2 antagonist
0,298  0,021  Carcinogenic, group 3
0,338  0,062  AR expression inhibitor
0,286  0,012  Pulmonary hypertension treatment
0,277  0,009  ATPase inhibitor
0,274  0,007  Aminoacyl-tRNA synthetase inhibitor
0,321  0,055  Antioxidant
0,270  0,005  Mucolytic
0,270  0,005  GABA C receptor antagonist
0,296  0,031  Antihypotensive
0,287  0,023  Skeletal muscle relaxant
0,312  0,049  Proliferative diseases treatment
0,284  0,022  Hair growth stimulant
0,298  0,037  Antiparkinsonian, rigidity relieving
0,263  0,005  Argininosuccinate synthase inhibitor
0,263  0,007  Arylamine N-Acetyltransferase substrate
0,275  0,020  CNS active muscle relaxant
0,265  0,011  Aminopeptidase B inhibitor
0,284  0,031  Peptidyltransferase inhibitor
0,326  0,074  ICAM1 expression inhibitor
0,322  0,071  Calcium channel activator
0,254  0,004  Peroxisome proliferator-activated receptor delta antagonist
0,256  0,006  Raynaud's phenomenon treatment
0,254  0,004  Aminopeptidase I inhibitor
0,255  0,006  Antirickettsial
0,272  0,024  Interferon gamma antagonist
0,391  0,145  Antiinflammatory
0,360  0,114  Antiarthritic
0,249  0,004  GST T1-1 substrate
0,259  0,014  Uterine stimulant
0,258  0,014  Cell wall synthesis inhibitor
0,263  0,025  Nitric-oxide synthase stimulant
0,248  0,010  UGT2B1 substrate
0,262  0,024  UGT2B15 substrate
0,261  0,024  Skin whitener
0,246  0,010  Antischistosomal
0,271  0,035  Non-steroidal antiinflammatory agent
0,238  0,003  Acyl-CoA dehydrogenase inhibitor
0,237  0,002  Antiviral (Parainfluenza)
0,237  0,004  Antidote, mercury
0,250  0,018  Antineoplastic antimetabolite
0,242  0,011  Microtubule formation inhibitor
0,236  0,005  Sphingosine 1-phosphate receptor 4 antagonist
0,236  0,005  GABA C receptor rho-1 antagonist
0,256  0,026  Antiparkinsonian, tremor relieving
0,235  0,005  Electrolyte absorption antagonist
0,243  0,013  Antiviral (Poxvirus)
0,248  0,018  Antifungal enhancer
0,246  0,017  SULT1A3 substrate
0,232  0,004  Sphingosine 1-phosphate receptor 2 antagonist
0,256  0,032  Lipocortins synthesis antagonist
0,229  0,005  Adenylate cyclase stimulant
0,229  0,006  Ornithine carbamoyltransferase inhibitor
0,269  0,048  Chemopreventive
0,260  0,038  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,251  0,032  Acaricide
0,230  0,012  Arachidonic acid antagonist
0,258  0,040  Muscle relaxant
0,358  0,142  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,233  0,018  Cystathionine beta-synthase inhibitor
0,218  0,004  Glutamate release inhibitor
0,229  0,016  Carcinogenic, group 2B
0,238  0,027  Antidote
0,266  0,056  Interleukin antagonist
0,220  0,011  Contraceptive female
0,209  0,002  Excitatory amino acid transporter 2 inhibitor
0,218  0,010  HDL-cholesterol increasing
0,222  0,015  Toll-Like receptor 2 antagonist
0,217  0,010  Selectin antagonist
0,211  0,004  Macrophage elastase inhibitor
0,215  0,010  Aldehyde dehydrogenase substrate
0,244  0,043  Pneumotoxic
0,251  0,051  Nitric oxide antagonist
0,228  0,029  Corneal wound healing stimulator
0,200  0,001  HMG CoA reductase inhibitor
0,248  0,050  RNA-directed DNA polymerase inhibitor
0,251  0,054  Antiviral (HIV)
0,276  0,079  Antineoplastic (pancreatic cancer)
0,224  0,027  Neuropathy treatment
0,200  0,004  Prostaglandin F2 alpha antagonist
0,224  0,030  Bone formation stimulant
0,209  0,017  SULT1A1 substrate
0,245  0,054  Platelet aggregation inhibitor
0,221  0,033  Phospholipase A2 inhibitor
0,195  0,007  Prostaglandin antagonist
0,234  0,048  Neurotrophic factor enhancer
0,198  0,013  Alcohol dehydrogenase inhibitor
0,189  0,005  Ca2+-transporting ATPase inhibitor
0,189  0,004  Plasminogen activator inhibitor antagonist
0,236  0,053  DNA methyltransferase I inhibitor
0,188  0,005  UGT2B11 substrate
0,193  0,012  Creatine kinase inhibitor
0,186  0,006  Paget's disease treatment
0,191  0,011  Folate antagonist
0,186  0,007  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,183  0,006  Antifungal (Pneumocystis)
0,179  0,003  Mannosidase inhibitor
0,192  0,019  Choleretic
0,218  0,045  Antianorexic
0,231  0,059  Antiviral (West Nile virus)
0,171  0,004  Alpha-mannosidase inhibitor
0,218  0,050  Diabetic retinopathy treatment
0,231  0,065  Anticonvulsant
0,183  0,017  Photosensitizer
0,189  0,025  Antifungal (Cryptococcus)
0,227  0,062  DNA methylase inhibitor
0,198  0,034  Monophenol monooxygenase inhibitor
0,186  0,021  Growth stimulant
0,177  0,013  Prolactin inhibitor
0,169  0,005  GABA aminotransferase inhibitor
0,205  0,042  Diuretic
0,174  0,011  Keratolytic
0,167  0,004  GABA B receptor agonist
0,173  0,011  Toll-Like receptor 4 antagonist
0,252  0,090  Antiosteoporotic
0,182  0,021  Coagulant
0,194  0,037  Antidiabetic (type 1)
0,159  0,003  Kynurenine 3 monooxygenase inhibitor
0,197  0,042  Melanin inhibitor
0,193  0,038  Genotoxic
0,160  0,005  ATPase (Vacuolar H+) inhibitor
0,168  0,014  DOPA decarboxylase inhibitor
0,171  0,019  HIV-1 integrase (Overall Integration) inhibitor
0,173  0,021  Sulfotransferase substrate
0,154  0,003  Free fatty acid receptor 1 agonist
0,210  0,061  CYP2B6 inhibitor
0,199  0,051  Antihelmintic (Nematodes)
0,164  0,016  Myasthenia Gravis treatment
0,155  0,007  NMDA receptor agonist
0,150  0,003  Lysine carboxypeptidase inhibitor
0,201  0,054  VEGF expression inhibitor
0,150  0,004  Glutamate (mGluR6) antagonist
0,153  0,006  Glycine receptor agonist
0,148  0,003  ATP citrate lysase inhibitor
0,177  0,031  Adenylate cyclase inhibitor
0,177  0,032  Antieczematic
0,161  0,017  Actinic keratosis treatment
0,187  0,044  Catenin beta inhibitor
0,179  0,035  DNA polymerase I inhibitor
0,153  0,012  Antimetabolite
0,174  0,032  Cathepsin H inhibitor
0,171  0,033  Antibacterial (Helicobacter pylori)
0,153  0,016  Anabolic
0,162  0,027  NAT2 substrate
0,147  0,012  Antifungal (Candida)
0,184  0,048  Contraceptive
0,139  0,004  Sphingosine 1-phosphate receptor agonist
0,220  0,085  Antiglaucomic
0,151  0,017  ABCA1 expression enhancer
0,158  0,024  Antiviral (Influenza B)
0,178  0,044  Antiprotozoal (Coccidial)
0,158  0,026  Protease inhibitor
0,176  0,045  GABA C receptor rho-2 antagonist
0,255  0,124  Transcription factor NF kappa B inhibitor
0,195  0,063  Antianginal
0,242  0,111  Metabolic disease treatment
0,143  0,013  Ornithine decarboxylase inhibitor
0,166  0,036  Cyclooxygenase 3 inhibitor
0,159  0,030  Vanilloid 1 agonist
0,143  0,014  Glutathione S-transferase inhibitor
0,135  0,008  Anticholelithogenic
0,179  0,051  Neurotensin receptor agonist
0,131  0,005  Sphingosine 1-phosphate receptor 5 agonist
0,135  0,009  Purinergic P2X1 antagonist
0,139  0,014  NAT1 substrate
0,164  0,041  Sphingosine 1-phosphate receptor 5 antagonist
0,135  0,012  Sphingosine 1-phosphate receptor 4 agonist
0,132  0,010  Antidote, heavy metal
0,126  0,004  Anesthetic inhalation
0,150  0,028  AMP-activated protein kinase stimulant
0,137  0,015  Restless leg syndrome treatment
0,150  0,029  Antihelmintic (Fasciola)
0,131  0,012  Integrin antagonist
0,123  0,005  Antidote, organophosphates
0,121  0,003  Sodium-dependent vitamin C transporter 2 inhibitor
0,122  0,004  SULT2A1 substrate
0,168  0,050  Pancreatic disorders treatment
0,129  0,014  Leukotriene antagonist
0,134  0,019  Tourette's syndrome treatment
0,153  0,039  Heat shock protein 70 antagonist
0,125  0,011  Endothelin-converting enzyme inhibitor
0,126  0,013  Toll-Like receptor 2 agonist
0,166  0,054  Antiacne
0,237  0,125  Immunomodulator
0,203  0,091  Cyclic AMP phosphodiesterase inhibitor
0,164  0,054  Hemostatic
0,114  0,004  Adenine nucleotide translocase inhibitor
0,117  0,008  Antitreponemal
0,115  0,006  Sphingosine 1-phosphate receptor 1 antagonist
0,122  0,014  GP IIb/IIIa receptor antagonist
0,115  0,007  Thromboxane antagonist
0,118  0,010  Phosphorylase inhibitor
0,152  0,045  Alkylator
0,160  0,053  Antianemic
0,111  0,005  Nitric oxide donor
0,110  0,003  Arginase inhibitor
0,115  0,010  Peroxisome proliferator-activated receptor alpha agonist
0,110  0,005  Thromboxane synthase inhibitor
0,122  0,018  Bile acid receptor antagonist
0,114  0,009  Vanilloid 4 agonist
0,110  0,006  Sphingosine 1-phosphate receptor 3 antagonist
0,133  0,030  Uric acid excretion stimulant
0,126  0,025  Lanosterol 14 alpha demethylase inhibitor
0,161  0,060  Thiol protease inhibitor
0,107  0,005  Leukotriene D4 antagonist
0,181  0,080  Wound healing agent
0,106  0,004  Lysophosphatidic acid 3 receptor antagonist
0,220  0,119  Antiepileptic
0,114  0,014  Cathepsin D inhibitor
0,180  0,080  P-glycoprotein inhibitor
0,199  0,100  Antineoplastic (lymphocytic leukemia)
0,176  0,078  LDLR expression enhancer
0,137  0,039  Caspase 3 inhibitor
0,105  0,007  Thromboxane A2 antagonist
0,113  0,015  Sphingosine 1-phosphate receptor antagonist
0,109  0,011  Caspase 9 inhibitor
0,117  0,020  Glycine receptor antagonist
0,100  0,003  Glutamate (mGluR8) agonist
0,101  0,005  Prostaglandin agonist
0,115  0,019  Interferon agonist
0,100  0,004  Sphingosine 1-phosphate receptor 1 agonist
0,106  0,011  Antimycoplasmal
0,108  0,013  NMDA receptor glycine site agonist
0,137  0,044  Gout treatment
0,095  0,002  Excitatory amino acid transporter 1 inhibitor
0,120  0,027  Antibiotic
0,184  0,092  Antiviral (Ebola)
0,206  0,114  Spasmolytic
0,100  0,009  Exportin-1 inhibitor
0,162  0,071  Anticoagulant
0,127  0,036  Sphingomyelinase inhibitor
0,128  0,039  Carbonic anhydrase III inhibitor
0,103  0,014  Neuraminidase inhibitor
0,093  0,004  Prostaglandin EP4 agonist
0,102  0,013  Phospholipase D inhibitor
0,129  0,040  Anticataract
0,133  0,045  TRPA1 agonist
0,099  0,011  Glutamate (mGluR7) antagonist
0,093  0,006  Prostaglandin EP3 antagonist
0,115  0,028  Cathepsin G inhibitor
0,168  0,082  Myocardial ischemia treatment
0,109  0,024  Na+ K+ transporting ATPase inhibitor
0,120  0,035  Interleukin 1 beta converting enzyme inhibitor
0,089  0,004  Membrane dipeptidase inhibitor
0,156  0,072  Hexokinase inhibitor
0,089  0,005  Glucagon-like peptide 1 receptor antagonist
0,151  0,068  Movement disorders treatment
0,171  0,087  Platelet adhesion inhibitor
0,165  0,083  Phobic disorders treatment
0,103  0,021  Estrogen-related receptor beta agonist
0,117  0,036  Carcinogenic, group 2A
0,100  0,019  Ribonucleoside-diphosphate reductase inhibitor
0,100  0,021  Ribonucleotide reductase inhibitor
0,085  0,005  Prostacyclin antagonist
0,087  0,008  Phosphoglycerate kinase inhibitor
0,083  0,004  Kainate receptor agonist
0,096  0,018  Peroxisome proliferator-activated receptor gamma antagonist
0,089  0,012  MDM2 inhibitor
0,097  0,019  Carbonic anhydrase stimulant
0,093  0,016  Cathepsin E inhibitor
0,128  0,050  Shock treatment
0,126  0,049  Chelator
0,083  0,006  Nicotinic acid receptor agonist
0,089  0,013  Leukotriene B4 antagonist
0,114  0,037  Glutamate (mGluR7) agonist
0,141  0,065  Psychosexual dysfunction treatment
0,104  0,030  Granulocyte macrophage colony stimulating factor agonist
0,077  0,004  Prostacyclin agonist
0,080  0,008  Retinoid X receptor agonist
0,098  0,026  Narcotic antagonist
0,084  0,011  CD45 antagonist
0,098  0,026  HIV-1 integrase inhibitor
0,111  0,040  NMDA receptor antagonist
0,103  0,032  Antiprotozoal activity enhancer
0,073  0,004  Glutamate (mGluR1) agonist
0,111  0,042  Posttraumatic stress disorder treatment
0,074  0,005  Glutamate (mGluR3) antagonist
0,153  0,085  Prostate disorders treatment
0,071  0,003  Prostaglandin F2 alpha agonist
0,078  0,010  Adenosine deaminase inhibitor
0,196  0,128  Neuropeptide Y2 antagonist
0,075  0,008  AICAR transformylase inhibitor
0,070  0,004  Prostaglandin D2 agonist
0,075  0,009  Squalene synthetase inhibitor
0,092  0,026  Glucagon-like peptide 1 agonist
0,086  0,020  Beta 3 adrenoreceptor antagonist
0,091  0,026  Hyperparathyroidism treatment
0,073  0,007  Purinergic P2T antagonist
0,085  0,020  Interferon inducer
0,072  0,006  GABA uptake inhibitor
0,100  0,035  Hematopoietic
0,075  0,010  Leukotriene C antagonist
0,090  0,027  HIV-1 integrase (Strand Transfer) inhibitor
0,179  0,116  Free radical scavenger
0,069  0,006  Glucagon receptor antagonist
0,085  0,022  Neuraminidase (influenza) inhibitor
0,130  0,069  Retinoprotector
0,111  0,050  Factor V inhibitor
0,067  0,006  Guanylate cyclase inhibitor
0,066  0,006  Prostaglandin EP4 antagonist
0,067  0,008  Endothelin receptor antagonist
0,068  0,010  Sphingosine 1-phosphate receptor 3 agonist
0,098  0,041  Transcription factor NF kappa B stimulant
0,067  0,009  Peroxisome proliferator-activated receptor delta agonist
0,062  0,005  Prostaglandin E2 agonist
0,062  0,005  Prostaglandin D2 antagonist
0,087  0,031  HIV-1 integrase (3'-Processing) inhibitor
0,094  0,038  D-Ala-D-Ala ligase inhibitor
0,069  0,015  Pregnane X receptor antagonist
0,139  0,085  NOS3 expression enhancer
0,118  0,064  Menstruation disorders treatment
0,058  0,005  Prostaglandin EP2 agonist
0,080  0,027  Beta adrenoreceptor antagonist
0,110  0,058  Mediator release inhibitor
0,166  0,114  Antiparasitic
0,056  0,003  Lysophosphatidic acid receptor 1 agonist
0,071  0,019  Angiotensin-converting enzyme inhibitor
0,145  0,093  Hearing loss treatment
0,070  0,018  Ryanodine receptor antagonist
0,107  0,055  Chronic obstructive bronchitis treatment
0,063  0,011  Microtubule stabilization
0,127  0,076  Anesthetic
0,053  0,002  Carbonic anhydrase X inhibitor
0,053  0,002  Carbonic anhydrase VIII inhibitor
0,092  0,042  Carbonic anhydrase XIII inhibitor
0,056  0,006  Glutamate (mGluR8) antagonist
0,065  0,016  Heparanase inhibitor
0,100  0,051  Phosphodiesterase 6D inhibitor
0,053  0,004  Glutamate (mGluR3) agonist
0,056  0,007  Cholesterol absorption inhibitor
0,060  0,011  Retinoid X alpha receptor agonist
0,056  0,007  Lysophosphatidic acid 2 receptor antagonist
0,054  0,006  Leukotriene B4 receptor 1 antagonist
0,061  0,013  Geranyltranstransferase inhibitor
0,075  0,027  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,072  0,024  Beta 1 adrenoreceptor antagonist
0,156  0,109  Antiviral (Influenza)
0,065  0,017  Purinergic P2Y antagonist
0,066  0,020  DNA helicase inhibitor
0,053  0,007  Plasmepsin I inhibitor
0,049  0,003  Excitatory amino acid transporter 3 inhibitor
0,079  0,032  Endocannabinoid uptake inhibitor
0,059  0,013  GABA B receptor antagonist
0,089  0,044  NAD(P)H dehydrogenase (quinone) inhibitor
0,066  0,021  Bombesin 2 receptor antagonist
0,093  0,049  Antineoplastic antibiotic
0,052  0,008  Uridine phosphorylase inhibitor
0,120  0,077  Antiviral (Papilloma)
0,045  0,002  Thromboxane A2 agonist
0,062  0,020  Immunoglobulin Fc receptor antagonist
0,051  0,009  Free fatty acid receptor 1 antagonist
0,060  0,017  Thymidylate synthase inhibitor
0,051  0,009  Hypoxanthine phosphoribosyltransferase inhibitor
0,054  0,012  Angiotensin AT1 receptor antagonist
0,057  0,015  Calcitonin receptor agonist
0,068  0,027  Botulinum neurotoxin type A inhibitor
0,043  0,002  Thromboxane agonist
0,100  0,060  Xanthine oxidase inhibitor
0,056  0,015  Glutamate (mGluR group III) antagonist
0,087  0,046  Metalloproteinase-2 inhibitor
0,050  0,010  Leukotriene C4 antagonist
0,053  0,012  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,047  0,006  Endothelin A receptor antagonist
0,041  0,001  Excitatory amino acid transporter 4 inhibitor
0,056  0,016  Neuraminidase (Influenza A) inhibitor
0,111  0,071  Mental retardation treatment
0,069  0,030  Calcium channel P-type blocker
0,068  0,028  Aldose reductase inhibitor
0,048  0,009  Integrin alpha1beta1 antagonist
0,051  0,012  Heme oxygenase inhibitor
0,091  0,053  Tocolytic
0,134  0,095  Acute respiratory distress syndrome (ARDS) treatment
0,048  0,011  VCAM-1 antagonist
0,042  0,005  Integrin alphaVbeta1 antagonist
0,048  0,011  VCAM antagonist
0,081  0,044  MAP kinase kinase 7 inhibitor
0,045  0,009  Carboxypeptidase B inhibitor
0,049  0,013  Retinoid X receptor antagonist
0,048  0,012  Caspase 2 inhibitor
0,054  0,018  Glutamate (mGluR4) antagonist
0,039  0,003  Lysophosphatidic acid receptor 3 agonist
0,041  0,005  Glutamate (mGluR1a) agonist
0,139  0,104  Muscular dystrophy treatment
0,076  0,040  Leukotriene synthesis inhibitor
0,046  0,011  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,044  0,009  Tryptophan 5 hydroxylase inhibitor
0,085  0,051  Adrenaline agonist
0,087  0,053  mTOR complex 2 inhibitor
0,140  0,106  Interleukin 6 antagonist
0,120  0,087  Antiprotozoal (Trichomonas)
0,085  0,052  Carbonic anhydrase VI inhibitor
0,038  0,005  Toll-Like receptor 4 agonist
0,052  0,019  HIV-1 protease inhibitor
0,034  0,003  Glutamate (mGluR6) agonist
0,162  0,130  Antialcoholic
0,036  0,005  Lysophosphatidic acid 1 receptor antagonist
0,058  0,026  Beta 2 adrenoreceptor antagonist
0,043  0,011  GABA transporter 3 inhibitor
0,040  0,009  Purinergic P2Y12 antagonist
0,042  0,012  Angiotensin II receptor antagonist
0,038  0,008  Vitronectin receptor antagonist
0,122  0,092  Lipid peroxidase inhibitor
0,037  0,007  Prostaglandin H2 antagonist
0,042  0,013  Retinoid X alpha receptor antagonist
0,055  0,026  Antiviral (Herpesvirus 3, Human)
0,034  0,005  N-Acetylated alpha-linked acidic dipeptidase inhibitor
0,052  0,024  Adenylate cyclase 1 inhibitor
0,049  0,021  Leukotriene A4 hydrolase inhibitor
0,048  0,020  Thymidine kinase inhibitor
0,063  0,034  Sphingosine kinase inhibitor
0,030  0,002  Methylmalonyl-CoA mutase inhibitor
0,037  0,010  Peroxisome proliferator-activated receptor alpha antagonist
0,035  0,008  Endothelin B receptor antagonist
0,044  0,016  Integrin alpha2 antagonist
0,067  0,040  Protease 3C (Human rhinovirus) inhibitor
0,040  0,013  Cholesterol ester transfer protein antagonist
0,070  0,044  Matrix metalloproteinase inhibitor
0,134  0,108  CF transmembrane conductance regulator agonist
0,032  0,007  GRP78 expression inhibitor
0,058  0,032  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,038  0,013  Methionyl aminopeptidase 1 inhibitor
0,032  0,007  Integrin alphaVbeta3 antagonist
0,046  0,021  Dopamine D5 agonist
0,051  0,027  Cytokine production stimulant
0,032  0,008  Vanilloid 2 agonist
0,029  0,005  Neuraminidase (Influenza B) inhibitor
0,050  0,026  Complement C3a chemotactic receptor antagonist
0,106  0,083  Antiprotozoal (Babesia)
0,028  0,005  G-protein-coupled receptor 120 agonist
0,054  0,031  Diacylglycerol O-acyltransferase inhibitor
0,044  0,021  Renin inhibitor
0,029  0,006  Isoleucine-tRNA ligase inhibitor
0,029  0,007  Aminopeptidase A inhibitor
0,182  0,160  Transcription factor STAT3 inhibitor
0,027  0,005  Retinoid X beta receptor antagonist
0,041  0,019  Vanilloid 3 antagonist
0,047  0,026  Beta adrenoreceptor agonist
0,044  0,023  Integrin alpha5beta1 antagonist
0,023  0,003  Calcineurin inhibitor
0,105  0,085  Interleukin 8 antagonist
0,025  0,005  Vesicular glutamate transport inhibitor
0,033  0,013  Purinergic P2Y15 antagonist
0,031  0,011  Hedgehog signaling activator
0,051  0,031  HCV NS3/NS4A protease inhibitor
0,045  0,025  Kainate receptor antagonist
0,040  0,020  p53 inhibitor
0,051  0,032  Squalene epoxidase inhibitor
0,051  0,032  Topoisomerase II beta inhibitor
0,037  0,019  Carnitine palmitoyltransferase inhibitor
0,093  0,075  Gastric antisecretory
0,072  0,054  S-adenosyl-L-methionine decarboxylase inhibitor
0,023  0,005  Telomerase stimulant
0,059  0,042  Collagenase 3 inhibitor
0,055  0,038  Matrix metalloproteinase (membrane-type) inhibitor
0,024  0,007  Ileal bile acid transport inhibitor
0,049  0,032  Dopamine beta hydroxylase inhibitor
0,057  0,039  Postcoital contraceptive
0,049  0,031  Aldosterone antagonist
0,039  0,022  Kainate receptor 2 antagonist
0,136  0,118  Sedative
0,055  0,038  Sphingosine kinase 2 inhibitor
0,041  0,025  AMPA 4 receptor antagonist
0,036  0,020  Carnitine palmitoyltransferase 1 inhibitor
0,028  0,012  Aminopeptidase P inhibitor
0,022  0,006  Vitamin D receptor agonist
0,040  0,024  Farnesoid X receptor agonist
0,093  0,078  mTOR complex 1 inhibitor
0,052  0,036  NMDA 2A receptor antagonist
0,027  0,011  Leukotriene B4 receptor 2 antagonist
0,029  0,013  Thyroid hormone agonist
0,034  0,019  Nucleoside transporters inhibitor
0,025  0,009  GABA transporter inhibitor
0,020  0,004  Integrin beta6 antagonist
0,025  0,011  Integrin beta3 antagonist
0,045  0,030  NMDA receptor subunit 3B antagonist
0,017  0,003  Mannitol 2-dehydrogenase inhibitor
0,113  0,099  Antihemorrhagic
0,025  0,011  Integrin beta5 antagonist
0,047  0,033  Glycine transporter 2 inhibitor
0,029  0,015  Retinoid X gamma receptor antagonist
0,109  0,095  Antismoking
0,165  0,151  DNA damaging
0,017  0,003  Folate transporter 1 inhibitor
0,018  0,005  Carbonic anhydrase XI inhibitor
0,028  0,015  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,030  0,016  Integrin alpha4 antagonist
0,023  0,010  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,065  0,053  Gaucher disease treatment
0,101  0,088  Beta amyloid protein antagonist
0,024  0,012  Integrin beta7 antagonist
0,021  0,009  Antibiotic Anthracycline-like
0,041  0,029  Plasmepsin II inhibitor
0,056  0,045  Lipocortins synthesis agonist
0,109  0,098  DNA repair enzyme inhibitor
0,022  0,010  Caspase 8 inhibitor
0,095  0,084  Nav1.4 sodium channel blocker
0,099  0,089  Proteasome inhibitor
0,039  0,029  Dihydropteroate synthase inhibitor
0,015  0,006  Calcium-dependent phospholipase A2 inhibitor
0,180  0,171  Antipsoriatic
0,131  0,122  Antipruritic
0,076  0,067  Calcium antagonist
0,017  0,008  GABA transporter 1 inhibitor
0,052  0,043  Carbonic anhydrase VB inhibitor
0,040  0,032  Sphingosine kinase 1 inhibitor
0,029  0,021  AMPA 3 receptor antagonist
0,060  0,051  Beta 2 adrenoreceptor agonist
0,037  0,029  Urate transporter 1 inhibitor
0,068  0,060  Metalloproteinase-9 inhibitor
0,049  0,041  Protein 50S ribosomal subunit inhibitor
0,036  0,028  NMDA receptor subunit 3A antagonist
0,023  0,016  Retinoid X gamma receptor agonist
0,017  0,009  Calcium-sensing receptor antagonist
0,052  0,045  Dihydroorotate oxidase inhibitor
0,040  0,033  Glutamate (mGluR group III) agonist
0,015  0,008  Integrin alphaVbeta6 antagonist
0,080  0,073  Antileprosy
0,016  0,010  Purinergic P2Y1 agonist
0,070  0,063  SULT1A2 substrate
0,021  0,015  Retinoid X beta receptor agonist
0,026  0,020  Nicotinic acid receptor 2 antagonist
0,067  0,061  CDC25A inhibitor
0,029  0,024  Caspase 6 inhibitor
0,126  0,121  Liver fibrosis treatment
0,033  0,028  Calcium-independent phospholipase A2 inhibitor
0,088  0,083  Falcipain 3 inhibitor
0,076  0,071  Caspase 7 inhibitor
0,135  0,130  Antihelmintic
0,009  0,004  Integrin alpha5beta6 antagonist
0,020  0,015  Integrin alpha4beta7 antagonist
0,127  0,123  Cystic fibrosis treatment
0,034  0,030  5-Alpha-reductase inhibitor
0,044  0,040  Metalloproteinase-3 inhibitor
0,084  0,080  Antiviral (Rhinovirus)
0,123  0,120  Pregnane X receptor agonist
0,033  0,030  Antibiotic Aminoglycoside-like
0,057  0,054  Neutrophil collagenase inhibitor
0,018  0,015  Vesicular acetylcholine transporter inhibitor
0,060  0,057  Uterine relaxant
0,063  0,060  Amidase inhibitor
0,025  0,022  Integrin alpha2beta1 antagonist
0,011  0,008  Carboxypeptidase B2 inhibitor
0,026  0,023  LFA antagonist
0,055  0,052  NMDA 2C receptor antagonist
0,070  0,067  Macrophage migration inhibitory factor inhibitor
0,023  0,020  VLA-4 antagonist
0,023  0,021  Methionyl aminopeptidase 2 inhibitor
0,061  0,059  Carbonic anhydrase VA inhibitor
0,007  0,005  Phosphoribosylglycinamide formyltransferase inhibitor
0,037  0,036  Carbonic anhydrase IV inhibitor
0,092  0,091  Anesthetic local
0,033  0,032  G protein-coupled receptor agonist
0,011  0,010  Purine nucleoside phosphorylase inhibitor
0,043  0,043  Prostaglandin E2 antagonist
0,018  0,017  Kainate receptor 1 antagonist

